Pioneering cancer drug combination approved

A pioneering pair of cancer drugs that unleash the immune system on tumours will be paid for by the NHS in England. In trials, the combination therapy shrank the most aggressive and deadly type of skin cancer in 69% of patients. The decision to approve the drugs is one of the fastest in NHS history …